Influencers · 21 November 2026
Dubai meeting reinforces UAE ban on medical product influencer promotions

The Emirates Drug Establishment has reaffirmed that social media influencers cannot promote or endorse medical products in the UAE. The regulator restated the restriction during its Medical Product Advertising Customer Council at the Government Accelerators Centre in Emirates Towers, Dubai, on 18 November 2026, alongside a reminder that medical advertisements require approval before they are published or circulated.
- EDE reiterated an existing prohibition on medical product promotion and endorsement through social media influencers.
- Medical advertising requires advance approval, whether it appears online, in print, on broadcast media or on outdoor screens.
- Promotional information must be accurate and verifiable, with relevant risks, possible side effects and necessary warnings clearly disclosed.
- The Dubai council covered approval procedures, advertising monitoring and the removal of content that breaches regulatory requirements.
Quick summary
The central message from the Dubai meeting was that medical product advertising is subject to specific regulatory controls, including a prohibition on using social media influencers for promotion. EDE presented this as a continuing restriction, rather than announcing that influencer endorsements would become permissible through its advertising approval process.
Industry representatives, partners and customers attended the council, where discussions covered promotional claims, digital platforms and the requirements governing medical advertisements. Prescription-only medicines were also addressed, including the restrictions and approval obligations attached to their promotion.
According to the Gulf News report, updated on 20 November 2026, EDE linked the discussions to its work on consumer protection and responsible medical product use. The meeting also gave participants an opportunity to ask questions about compliance and explain where the approval process could be clearer.
Why it matters for Dubai
Although the council took place in Dubai, the announcement concerned the UAE regulator's requirements for medical product advertising. For Dubai creators and businesses considering promotional content, the significance is the clear distinction between ordinary creator activity and the prohibited use of influencers to advertise or endorse medical products.
The meeting also underlined that choosing a different advertising channel does not remove the obligation to follow approved standards. EDE listed print, television, radio, outdoor advertising screens, websites and social media among the media covered by its requirements.
That makes the announcement relevant beyond an individual social post. Businesses planning medical product publicity must consider both the proposed content and the way it will reach audiences. The regulator's message was consistent across those channels: medical advertising needs prior approval, and influencer promotion remains prohibited. Neither requirement was presented as a substitute for the other.
What it means for creators and venues
For creators and venues planning Collabs, the immediate takeaway is narrowly defined but important: a medical product endorsement through a social media influencer is not permitted. The report does not describe a general prohibition on all venue Collabs, and its medical product focus should not be expanded into an unsupported claim about unrelated creator work.
Equally, the requirement for advertising approval should not be read as a route around the influencer restriction. EDE restated both points at the council, making clear that advance approval is mandatory for medical advertising while promotion through influencers remains barred.
When considering Collabs involving medical products, creators and venues should therefore distinguish between the advertising approval requirement and the separate restriction on who may promote the product. The source does not set out exceptions for particular influencer formats or arrangements, so it provides no basis for treating a different presentation style as an exemption.
Claims must match authorised product information
EDE's requirements extend to what an advertisement actually says. Medical promotional material must provide information that is clear, accurate and capable of verification. Its claims must also correspond to the product's approved specifications and authorised uses, rather than suggesting benefits beyond those parameters.
The regulator rejected misleading or exaggerated statements and stressed the need to disclose relevant risks, potential side effects and necessary warnings. Those disclosures must be appropriate to the product and the audience being addressed. The emphasis was therefore not simply on avoiding a false claim, but on communicating information needed to understand the product responsibly.
EDE also warned against advertising that encourages people to diagnose themselves or use treatments without suitable supervision from qualified healthcare professionals. This places the responsible presentation of medical information at the centre of the advertising rules, alongside the requirements governing approval and publication.
How the advertising approval process was discussed
Participants examined the procedures for applying for advertising approval through EDE's electronic licensing system. The discussion included the supporting documents and promotional materials that applicants must submit, with requirements depending on the advertisement type and the platform where it will appear.
The source does not provide a complete application checklist, processing timetable or fee schedule. What it does establish is that approval must come before publication or circulation. Preparing material for a particular channel does not remove that prior approval obligation.
Prescription-only medicine advertisements received separate attention during the council, including the restrictions and approval requirements relevant to that content. Industry representatives were also able to raise questions about the wider approval process. Their feedback formed part of discussions about simplifying procedures and making regulatory expectations easier to understand, rather than replacing the existing controls.
Monitoring includes action on non-compliant advertisements
The council's agenda went beyond applications and wording. It also covered how medical advertising is monitored across different media, including the identification of promotional material that does not meet regulatory requirements.
Participants discussed coordination with relevant authorities to remove advertisements that breach those requirements. The report does not specify fines, provide an enforcement timetable or identify individual creators or businesses facing action. Its account instead focuses on the mechanisms used to find non-compliant material and arrange its removal.
For anyone involved in medical advertising, this is a reminder that compliance is not confined to submitting an application. The content that reaches the public must also meet the regulator's standards. EDE connected its work in this area with improving compliance and protecting consumers, while maintaining its emphasis on the safe and responsible use of medical products.
Consumer protection remains the central message
EDE described the council as part of its effort to strengthen engagement with stakeholders while improving compliance with medical advertising rules. Bringing industry representatives, partners and customers into the discussion allowed questions about the process to sit alongside the regulator's reminders about prohibited promotion and unacceptable claims.
For Dubai's creator and venue community, the practical distinction is straightforward: medical product promotion cannot be treated as an ordinary influencer endorsement. The advertising approval system and the influencer prohibition remain separate considerations, both restated at the meeting.
The wider message is about the quality and responsibility of public-facing medical information. Accurate claims, suitable warnings and avoidance of content encouraging unsupervised treatment were all part of EDE's stated expectations. Discussions about clearer procedures did not change those expectations or signal that the influencer restriction had been relaxed.
FAQs
Can UAE influencers endorse medical products?
No. EDE reiterated that medical product promotion and endorsement through social media influencers remains prohibited.
Does medical advertising need approval before publication?
Yes. EDE requires approval before medical advertisements are published or circulated, regardless of the advertising medium.
Where was the council held?
It took place at the Government Accelerators Centre in Emirates Towers, Dubai, on 18 November 2026.
What claims are not permitted?
Misleading or exaggerated claims are prohibited, as is promotional content encouraging self-diagnosis or treatment without appropriate professional supervision.
Source: gulfnews.com. Image is an illustration.